Rita Poquette, NP
Family · Duarte, CANPI 1194937920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $277, more than ten times the $15 reported in 2021.
Across 19 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$83
- Teleflex LLC$69
- EMD Serono, Inc.$60
- Coloplast$55
- Sun Pharmaceutical Industries Inc.$53
- Genentech USA, Inc.$30
- plus $110 from 5 others
What the payments were for
- Food & beverage$459100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 3 | $83 |
| Teleflex LLC | 3 | $69 |
| EMD Serono, Inc. | 2 | $60 |
| Coloplast | 3 | $55 |
| Sun Pharmaceutical Industries Inc. | 2 | $53 |
| Genentech USA, Inc. | 1 | $30 |
| Merck | 1 | $25 |
| Bristol Myers Squibb | 1 | $24 |
| Bayer | 1 | $21 |
| Exelixis Inc. | 1 | $21 |
| Urogen Pharma, Inc. | 1 | $18 |
How this compares
$459 in reported general payments places this provider in the 60th percentile of 10,634 family providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 111 | $82,695 |
| GemtesaVibegron | 29 | $24,830 |
| Silodosin | 74 | $4,832 |
| Mirabegron ErMirabegron | 11 | $3,835 |
| Tamsulosin Hcl | 231 | $3,479 |
| Methenamine Hippurate | 48 | $2,729 |
| Solifenacin Succinate | 30 | $1,811 |
| Potassium Citrate ErPotassium Citrate | 12 | $1,202 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 79 | $1,150 |
| Trospium Chloride | 45 | $1,085 |
| Finasteride | 102 | $1,043 |
| Cefdinir | 91 | $807 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $784 |
| Dutasteride | 14 | $754 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $319 |
Paid to pharmacies, not to this prescriber.
Other family in Duarte
- Maria Elena Dela RosaDuarte$55K
- Marjorie HeinDuarte$50K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.